Compare Maravai LifeSciences Holdings Inc. Class A Common Stock (MRVI) vs Toyota Motor Corp (TM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Maravai LifeSciences Holdings Inc. Class A Common Stock vs Toyota Motor Corp — how do they compare? Maravai LifeSciences Holdings Inc. Class A Common Stock trades at $6.56 (market cap $972.90M), while Toyota Motor Corp trades at $192.52 (market cap $221.69B). The key difference: Toyota Motor Corp is far larger — about 227.9× Maravai LifeSciences Holdings Inc. Class A Common Stock's market cap, and Toyota Motor Corp pays a 3.32% dividend while Maravai LifeSciences Holdings Inc. Class A Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Maravai LifeSciences Holdings Inc. Class A Common Stock for 0 Days and Toyota Motor Corp for 116 Days on average.
| MRVI | TM | |
|---|---|---|
Market Cap | $972.90M | $221.69B |
Volume | 4,325,710 | 298,766 |
Sector | Health | Consumer Cyclical |
52-Week High | $9.00 | $248.29 |
52-Week Low | $2.83 | $166.50 |
Typical Hold Time | 0 Days | 116 Days |
Enterprise Value | $1.08B | $414.72B |
Dividend Yield | — | 3.32% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Maravai LifeSciences (MRVI) trades at $6.53, down 7.51% in the last session amid mixed signals. The stock shows improving fundamentals with Q2 2026 revenue growth of 9% and three consecutive earnings beats, though it remains unprofitable with a -37.07% net margin. Technical analysis indicates neutral positioning with key support at $6 and resistance at $7. Recent news highlights patent expansions in China and institutional accumulation.
The outlook remains cautiously optimistic with analyst consensus pointing to 7% upside potential to the $7.00 price target. Key opportunities include margin expansion and RNA technology leadership, while risks center on persistent cash burn and competitive pressures in life sciences. The stock offers speculative growth potential for risk-tolerant investors.
Toyota Motor trades at $188.60, up 2.1% with bearish technical signals but strong fundamentals. The stock shows attractive valuation with P/E of 8.5 and P/S of 0.74, supported by consistent earnings beats. Recent news highlights growing U.S. market share and electrification progress, though China sales remain a concern. Cash flow trends show recovery from 2025's negative position to projected $2.25T positive in 2026.
Toyota presents a value opportunity with solid profitability and market positioning, though technical weakness and China headwinds warrant caution. The 37.5% buy rating from analysts reflects divided sentiment despite strong fundamentals. Key catalysts include electrification expansion and U.S. market gains, while risks involve production disruptions and competitive pressures in key markets.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Maravai LifeSciences Holdings Inc. Class A Common Stock
Maravai LifeSciences Holdings Inc. is a life sciences company supporting drug therapy, diagnostic, and vaccine development through four operating brands: TriLink BioTechnologies (nucleic acid and mRNA synthesis), Cygnus Technologies (biologics safety testing), Glen Research (oligonucleotide synthesis materials), and Alphazyme (enzyme manufacturing). It serves biotech and biopharma customers from discovery through commercial manufacturing.
Read more on MRVI →About Toyota Motor Corp
Founded in 1937, Toyota is one of the world's largest automakers with 10.38 million units sold at retail in fiscal 2022 across its light vehicle brands. Brands include Toyota, Lexus, Daihatsu, and truck maker Hino.
Read more on TM →
